We are live on ! Find out more
VIA

Virtus Investment Advisers Portfolio holdings

AUM $363M
1-Year Est. Return 34.89%
This Fund
S&P 500
This Quarter Est. Return
+5.04%
1 Year Est. Return
+34.89%
3 Year Est. Return
+131.43%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$363M
AUM Growth
-$5.41M
Cap. Flow
+$2.38M
Cap. Flow %
0.66%
Top 10 Hldgs %
7.17%
Holding
495
New
34
Increased
285
Reduced
131
Closed
45

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$2.11M
2
HSY icon
Hershey
HSY
+$2.09M
3
GILD icon
Gilead Sciences
GILD
+$2.07M
4
REGN icon
Regeneron Pharmaceuticals
REGN
+$2.05M
5
EIX icon
Edison International
EIX
+$2.04M

Top Sells

Rank Stock Value
1
HBAN icon
Huntington Bancshares
HBAN
+$2.13M
2
TKO icon
TKO Group
TKO
+$2.13M
3
WAT icon
Waters Corp
WAT
+$2.09M
4
STT icon
State Street
STT
+$2.07M
5
AON icon
Aon
AON
+$2.04M

Sector Composition

Rank Sector Weight
1 Healthcare 31.87%
2 Financials 20.97%
3 Technology 10.66%
4 Industrials 10.62%
5 Consumer Discretionary 7.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RZLT icon
226
Rezolute
RZLT
$486M
$462K 0.13%
151,492
+3,697
+3% +$11.1K
TYRA icon
227
Tyra Biosciences
TYRA
$1.81B
$461K 0.13%
12,049
+293
+2% +$9.48K
BBDC icon
228
Barings BDC
BBDC
$860M
$461K 0.13%
55,991
-15,626
-22% -$137K
CGON icon
229
CG Oncology
CGON
$6.18B
$451K 0.12%
6,660
+163
+3% +$9.23K
SLRC icon
230
SLR Investment Corp
SLRC
$706M
$448K 0.12%
31,335
-5,109
-14% -$75.7K
WHF icon
231
WhiteHorse Finance
WHF
$140M
$448K 0.12%
60,566
+2,741
+5% +$18.9K
ORKA
232
Oruka Therapeutics
ORKA
$5.64B
$443K 0.12%
9,034
+220
+2% +$7.65K
ALLO icon
233
Allogene Therapeutics
ALLO
$618M
$441K 0.12%
180,588
+4,410
+3% +$8.84K
KOD icon
234
Kodiak Sciences
KOD
$2.65B
$437K 0.12%
11,451
+278
+2% +$7.18K
ACLX
235
DELISTED
Arcellx
ACLX
$436K 0.12%
3,794
+93
+3% +$8.21K
ARCC icon
236
Ares Capital
ARCC
$13.5B
$430K 0.12%
23,885
-2,859
-11% -$55.3K
NUVB icon
237
Nuvation Bio
NUVB
$2.26B
$430K 0.12%
100,151
+19,083
+24% +$106K
TECX
238
Tectonic Therapeutic
TECX
$579M
$427K 0.12%
13,799
+337
+3% +$8.29K
LENZ
239
LENZ Therapeutics
LENZ
$171M
$426K 0.12%
46,542
+8,868
+24% +$125K
ARDC
240
Are Dynamic Credit Allocation Fund
ARDC
$298M
$418K 0.12%
34,335
-4,563
-12% -$59K
BSL
241
Blackstone Senior Floating Rate 2027 Term Fund
BSL
$168M
$411K 0.11%
31,759
-3,454
-10% -$45.5K
DFTX
242
Definium Therapeutics
DFTX
$5.81B
$411K 0.11%
21,727
+529
+2% +$8.98K
SYRE icon
243
Spyre Therapeutics
SYRE
$8.93B
$409K 0.11%
8,110
+197
+2% +$7.43K
CNTA
244
DELISTED
Centessa Pharmaceuticals
CNTA
$409K 0.11%
10,286
+252
+3% +$6.45K
BKT icon
245
BlackRock Income Trust
BKT
$331M
$404K 0.11%
38,229
-7,489
-16% -$82.3K
MSDL icon
246
Morgan Stanley Direct Lending Fund
MSDL
$1.28B
$395K 0.11%
28,292
+2,011
+8% +$31.1K
BGB
247
Blackstone Strategic Credit 2027 Term Fund
BGB
$500M
$392K 0.11%
35,175
-6,831
-16% -$78.8K
BLW icon
248
BlackRock Limited Duration Income Trust
BLW
$491M
$389K 0.11%
30,934
-4,942
-14% -$66.6K
NTLA icon
249
Intellia Therapeutics
NTLA
$1.53B
$388K 0.11%
30,230
+737
+2% +$9.39K
ADMA icon
250
ADMA Biologics
ADMA
$1.9B
$385K 0.11%
42,683
+8,132
+24% +$128K
8 9
10
11 12

Similar funds

RC
Reik & Co New York $363M AUM 3.03% 1-Year Est. Return
WI
WBI Investments Red Bank, New Jersey $362M AUM 23.75% 1-Year Est. Return
MS
Millington Securities Red Bank, New Jersey $362M AUM
HS
HighVista Strategies Boston, Massachusetts $362M AUM 230.96% 1-Year Est. Return
SIAG
Safeguard Investment Advisory Group Corona, California $362M AUM 20.96% 1-Year Est. Return
BHBT
Burke & Herbert Bank & Trust Alexandria, Virginia $362M AUM 20.5% 1-Year Est. Return
WTFG
Wood Tarver Financial Group Boise, Idaho $362M AUM 14.75% 1-Year Est. Return
MA
Modus Advisors Excelsior, Minnesota $363M AUM 22.99% 1-Year Est. Return

Virtus Investment Advisers's Q1 2026 Portfolio in Review

As of Q1 2026, Virtus Investment Advisers held 495 positions worth $363M, down 1.5% from $368M the previous quarter. Its ten largest holdings account for 7.2% of the portfolio.

Virtus Investment Advisers's Q1 2026 filing shows 34 new, 285 increased, 131 reduced and 45 closed positions. Its largest new stake was Hershey: 9,903 shares worth $2.06M. The largest sale was Huntington Bancshares, an estimated $2.13M.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, up from 27% a quarter earlier, followed by Financials and Technology.

  • Virtus Investment Advisers's largest Q1 2026 buy was Hershey: 9,903 shares worth $2.06M.
  • Virtus Investment Advisers added most to Amgen in Q1 2026, an estimated $2.11M increase.
  • Virtus Investment Advisers's biggest Q1 2026 reduction was Micron Technology, cutting an estimated $1.56M.
  • Virtus Investment Advisers fully exited Huntington Bancshares in Q1 2026, selling an estimated $2.13M.
  • Virtus Investment Advisers's ten largest holdings make up 7.2% of its $363M portfolio in Q1 2026.
  • Virtus Investment Advisers opened 34 new positions and closed 45 in Q1 2026.
  • Virtus Investment Advisers's portfolio value fell 1.5% quarter-over-quarter to $363M.

Based on Virtus Investment Advisers's 13F filing for Q1 2026, filed 14 May 2026.